Identifying high-risk smouldering myeloma to improve patient outcomes
Dr Melissa Cantley hopes that those who have this pre-canerous condition will be able to be tested to understand their risk of developing myeloma.
- Myeloma
- Research
Tag: Myeloma
PBAC update on two myeloma drugs
These two myeloma drugs were not recommended for listing on the PBS.
- Myeloma
- Treatments and side-effects
Same cancer, same drug but our access to treatment was anything but consistent
They’re three women all battling an incurable type of blood cancer, but Neda, Nikki and Shirley have felt hardship in very different ways.
- Myeloma
Daratumumab – first new myeloma agent PBAC-recommended in years
The drug has received a positive recommendation for PBS listing.
- Advocacy and policy
- Myeloma
- Treatments and side-effects
Shirley’s “so well” on her latest treatment – daratumumab
Shirley Irwin has had radiotherapy and two transplants, had surgery, five different lines of treatment, and relapsed twice.
- Myeloma
- Treatments and side-effects
Research aims to improve QOL by decreasing treatment toxicity
Kate Vandyke is leading exciting research examining whether a new inhibitor can be used to prepare myeloma patients for therapies and increase their efficacy.
- Myeloma
- Research
One in 110,000: Neda’s Story
Neda has experienced first-hand the benefit of Leukaemia Foundation support services - all thanks to the generosity of Australians.
- Myeloma
Davina’s selfless generosity could spark research breakthrough
Through a Gift in her Will, Davina's been able to fund strategic research projects to help people with blood cancer.
- Myeloma
- Our supporters
- Research
Jeanette takes nothing for granted
- Myeloma
First ‘next generation’ genomic test available in six months
Australian patient outcomes in the rapidly changing fields of genomic testing and precision medicine has been accelerated by Leukaemia Foundation funding.
- Myeloma
- Research
